iRhythm Holdings (IRTC) Operating Income Growth (1y) (2016 - 2026)

iRhythm Holdings (IRTC) Operating Income Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.56%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 11.83%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 30.43%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 20.97%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 90.95%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -18.12%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 74.18%
10 iRhythm Holdings 3.65 Bn 3.10 Bn 141.35 Mn 50.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 50.29%
Dec 31, 2025 155.99%
Sep 30, 2025 83.24%
Jun 30, 2025 18.59%
Mar 31, 2025 14.64%
Dec 31, 2024 89.58%
Sep 30, 2024 -82.24%
Jun 30, 2024 -21.77%
Mar 31, 2024 3.46%
Dec 31, 2023 -89.30%
Sep 30, 2023 -30.91%
Jun 30, 2023 19.53%
Mar 31, 2023 18.63%
Dec 31, 2022 35.72%
Sep 30, 2022 9.43%
Jun 30, 2022 -38.01%
Mar 31, 2022 -76.73%
Dec 31, 2021 -236.07%
Sep 30, 2021 -389.43%
Jun 30, 2021 15.72%